GlassScriptPhysician profile
Zoya Furman
NPI 1083635205
$12,405.52
in general payments reported to CMS, 2019-2025
56 companies · $2,776 in 2025
The $2,776 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,084 · 2020: $953 · 2021: $1,347 · 2022: $1,293 · 2023: $2,078 · 2024: $1,875 · 2025: $2,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,649 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,648.99 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,119.79 | 2019-2025 | Repatha, Otezla, Repatha |
| Novo Nordisk INC | $1,282.81 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,112.57 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $846.76 | 2019-2025 | Airsupra, Breztri |
| Amarin Pharma, INC. | $434.31 | 2019-2021 | |
| Lilly USA, LLC | $433.27 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novartis Pharmaceuticals Corporation | $339.61 | 2019-2025 | |
| Abbott Laboratories | $336.82 | 2022-2024 | Xact, Freestyle Libre 3 |
| Therapeuticsmd, INC. | $292.90 | 2019-2020 | |
| Spr Therapeutics, INC | $267.37 | 2023 | Sprint Pns System |
| Journey Medical Corporation | $261.11 | 2025 | Emrosi |
| Astellas Pharma US INC | $237.75 | 2023-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $234.42 | 2019-2022 | |
| Eisai INC. | $218.37 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.35 | 2019-2025 | Jardiance |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoya Furman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.